{"id":{"repo_id":"cambridge","oai_identifier":"oai:www.repository.cam.ac.uk:1810/270233"},"canonical_url":"https://search.dev.ndltd.org/etd/cambridge/oai:www.repository.cam.ac.uk:1810/270233","repository":{"repo_id":"cambridge","name":"Cambridge University","base_url":"https://api.repository.cam.ac.uk/server/oai/request"},"display":{"title":"Establishing C. elegans as a high-throughput system for the identification of novel therapeutic strategies for Parkinson’s disease","abstract":"","abstract_html":null,"abstract_has_math":false,"creators":["Perni, Michele"],"institution":"University of Cambridge","degree_name":"Doctor of Philosophy (PhD)","degree_level":"Doctoral","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":["Dobson, Christopher"],"committee_chairs":[],"committee_members":[],"year":2017,"date_issued":"2017-12-01","date_published":"2017-12-01","updated_at":"2026-07-22T22:24:08Z","subjects":["α-synuclein","Parkinson's disease","C. elegans","Squalamine","Neurodegenerative diseases","Worm-tracking","Automation","Drug Discovery"],"languages":["en"],"rights":[],"rights_urls":["https://apollo8-f-pro.lib.cam.ac.uk/bitstreams/1e53ede9-5574-4a9c-afcf-9b5cf09a9047/download","https://www.rioxx.net/licenses/all-rights-reserved/"],"identifier_entries":[{"key":"dc:creator.authoridentifier","label":"Author Identifier","values":["0000000175938376"],"render_values":[{"text":"0000-0001-7593-8376","href":"https://orcid.org/0000-0001-7593-8376","code":true}]}]},"links":{"outbound_url":"https://doi.org/10.17863/CAM.17076","outbound_label":"DOI","outbound_source":"dc:identifier.doi"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Dobson, Christopher"]},{"key":"dc:contributor.sponsor","label":"Sponsor","values":["Centre For Misfolding Diseases (CMD) of Cambridge"]},{"key":"dc:creator","label":"Author","values":["Perni, Michele"]},{"key":"dc:creator.authoridentifier","label":"Author Identifier","values":["0000000175938376"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.issued","label":"Date","values":["2017-12-01"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Cambridge"]},{"key":"dc:relation.isreferencedby.uri","label":"Dc Relation Isreferencedby URI","values":["https://www.repository.cam.ac.uk/handle/1810/270233"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["Doctoral"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["Doctor of Philosophy (PhD)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["α-synuclein","Parkinson's disease","C. elegans","Squalamine","Neurodegenerative diseases","Worm-tracking","Automation","Drug Discovery"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["https://apollo8-f-pro.lib.cam.ac.uk/bitstreams/1e53ede9-5574-4a9c-afcf-9b5cf09a9047/download","https://www.rioxx.net/licenses/all-rights-reserved/"]},{"key":"dc:rights.embargotype","label":"Dc Rights Embargotype","values":["restricted"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.doi","label":"DOI","values":["10.17863/CAM.17076"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:format.checksum.md5","label":"Dc Format Checksum Md5","values":["87eda9de84448d1f82354d60eee3eb5f"]},{"key":"dc:title","label":"Title","values":["Establishing C. elegans as a high-throughput system for the identification of novel therapeutic strategies for Parkinson’s disease"]}]}],"canonical_facts":{"dc:contributor.advisor":["Dobson, Christopher"],"dc:contributor.sponsor":["Centre For Misfolding Diseases (CMD) of Cambridge"],"dc:creator":["Perni, Michele"],"dc:creator.authoridentifier":["0000000175938376"],"dc:date.issued":["2017-12-01"],"dc:format.checksum.md5":["87eda9de84448d1f82354d60eee3eb5f"],"dc:identifier.doi":["10.17863/CAM.17076"],"dc:language":["en"],"dc:publisher.institution":["University of Cambridge"],"dc:relation.isreferencedby.uri":["https://www.repository.cam.ac.uk/handle/1810/270233"],"dc:rights":["https://apollo8-f-pro.lib.cam.ac.uk/bitstreams/1e53ede9-5574-4a9c-afcf-9b5cf09a9047/download","https://www.rioxx.net/licenses/all-rights-reserved/"],"dc:rights.embargotype":["restricted"],"dc:subject":["α-synuclein","Parkinson's disease","C. elegans","Squalamine","Neurodegenerative diseases","Worm-tracking","Automation","Drug Discovery"],"dc:title":["Establishing C. elegans as a high-throughput system for the identification of novel therapeutic strategies for Parkinson’s disease"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["Doctoral"],"dc:type.qualificationname":["Doctor of Philosophy (PhD)"]},"updated_at":"2026-07-22T22:24:08Z"}